Published in Brain Res on July 09, 1976
Blood-brain barrier protein recognized by monoclonal antibody. Proc Natl Acad Sci U S A (1987) 1.27
Expression of Tight Junction and Drug Efflux Transporter Proteins in an in vitro Model of Human Blood-Brain Barrier. Front Psychiatry (2012) 0.90
In vitro models of the blood-brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use. J Cereb Blood Flow Metab (2016) 0.90
Purification and characterization of metabolically active capillaries of the blood-brain barrier. Biochem J (1991) 0.83
Semicarbazide-sensitive amine oxidase (SSAO) and its possible contribution to vascular damage in Alzheimer's disease. J Neural Transm (Vienna) (2007) 0.80
A new model for multiple sclerosis: chronic experimental allergic encephalomyelitis induced by immunization with cerebral endothelial cell membrane. Acta Neuropathol (1987) 0.75
Abcb1 in Pigs: Molecular cloning, tissues distribution, functional analysis, and its effect on pharmacokinetics of enrofloxacin. Sci Rep (2016) 0.75
Cellular enzymatic differentiation in brain vessels of normal and protein-deprived rats. Biochemical studies. Acta Neuropathol (1983) 0.75
Internal tandem duplication of the flt3 gene found in acute myeloid leukemia. Leukemia (1996) 5.06
Presidental address. Neuropathological aspects of brain edema. J Neuropathol Exp Neurol (1967) 4.06
In vitro activity of DR-3355, an optically active ofloxacin. Antimicrob Agents Chemother (1988) 4.03
Occludin-deficient embryonic stem cells can differentiate into polarized epithelial cells bearing tight junctions. J Cell Biol (1998) 3.62
The blood-brain barrier to proteins under normal and pathological conditions. J Neurol Sci (1970) 3.18
Experimental cerebral ischemia in mongolian gerbils. I. Light microscopic observations. Acta Neuropathol (1975) 3.15
An atypical PKC directly associates and colocalizes at the epithelial tight junction with ASIP, a mammalian homologue of Caenorhabditis elegans polarity protein PAR-3. J Cell Biol (1998) 3.04
Selective vulnerability of the blood-brain barrier in chemically induced lesions. J Neuropathol Exp Neurol (1966) 2.88
Afadin: A novel actin filament-binding protein with one PDZ domain localized at cadherin-based cell-to-cell adherens junction. J Cell Biol (1997) 2.82
Anomalous systemic arterial supply to normal basal segments of the left lower lobe. Ann Thorac Surg (1999) 2.61
Role of c-kit in mouse spermatogenesis: identification of spermatogonia as a specific site of c-kit expression and function. Development (1991) 2.35
Housework, paid work, and depression among husbands and wives. J Health Soc Behav (1994) 2.05
Tyrosine phosphorylation of caveolin-1 in the endothelium. Exp Cell Res (1999) 1.89
Lactacystin, a novel microbial metabolite, induces neuritogenesis of neuroblastoma cells. J Antibiot (Tokyo) (1991) 1.86
The effects of 5-minute ischemia in Mongolian gerbils: II. Changes of spontaneous neuronal activity in cerebral cortex and CA1 sector of hippocampus. Acta Neuropathol (1983) 1.78
Endothelial progenitor cells correlate with lesion volume and growth in acute stroke. Neurology (2010) 1.69
Requirement of Runx1/AML1/PEBP2alphaB for the generation of haematopoietic cells from endothelial cells. Genes Cells (2001) 1.65
The effects of 5-minute ischemia in Mongolian gerbils: I. Blood-brain barrier, cerebral blood flow, and local cerebral glucose utilization changes. Acta Neuropathol (1983) 1.60
Thrombin-induced exposure and prostacyclin inhibition of the receptor for factor VIII/von Willebrand factor on human platelets. J Clin Invest (1982) 1.59
Evaluation of the dye-protein tracers in pathophysiology of the blood-brain barrier. Acta Neuropathol (1981) 1.58
The biphasic opening of the blood-brain barrier to proteins following temporary middle cerebral artery occlusion. Acta Neuropathol (1985) 1.55
Pathophysiological aspects of brain edema. Acta Neuropathol (1987) 1.54
Isolated trigeminal nerve metastases from breast cancer: an unusual cause of trigeminal mononeuropathy. Surg Neurol (1998) 1.47
Magnetic resonance imaging findings in cerebral fat embolism: correlation with clinical manifestations. J Trauma (1999) 1.42
Increased permeability of cerebral vessels to horseradish peroxidase induced by ischemia in Mongolian Gerbils. Acta Neuropathol (1976) 1.40
Effects of antihypertensive agents on circadian blood pressure in hypertensive patients with previous brain infarction. J Hum Hypertens (1997) 1.39
Autologous bone marrow transplantation in children with advanced neuroblastoma. Cancer (1994) 1.39
Bcl-2 expression and prognosis in childhood acute leukemia. Children's Cancer and Leukemia Study Group. Pediatr Hematol Oncol (1998) 1.39
Catastrophic antiphospholipid antibody syndrome in systemic lupus erythematosus: an autopsy case report of a young woman. Intern Med (2000) 1.39
Role of pressure gradients and bulk flow in dynamics of vasogenic brain edema. J Neurosurg (1977) 1.38
The effect of acute arterial hypertension on the blood-brain barrier to protein tracers. Acta Neuropathol (1970) 1.37
Structure of lactacystin, a new microbial metabolite which induces differentiation of neuroblastoma cells. J Antibiot (Tokyo) (1991) 1.34
The power of product integrity. Harv Bus Rev (1991) 1.34
Role of extracellular proteins in the dynamics of vasogenic brain edema. Acta Neuropathol (1985) 1.31
Adenosine diphosphate induces binding of von Willebrand factor to human platelets. Nature (1982) 1.31
Epithelial expression of interleukin-37b in inflammatory bowel disease. Clin Exp Immunol (2013) 1.28
New observations on the pathogenesis of multiple intestinal atresias. J Pediatr Surg (1988) 1.26
Testing of a hypothesis for osmotic opening of the blood-brain barrier. Am J Physiol (1972) 1.25
Tiotropium 5microg via Respimat and 18microg via HandiHaler; efficacy and safety in Japanese COPD patients. Respir Med (2009) 1.24
The blood-brain barrier to protein tracers in focal cerebral ischemia and infarction caused by occlusion of the middle cerebral artery. Acta Neuropathol (1971) 1.24
Evaluation of aberrant bile ducts before laparoscopic cholecystectomy: helical CT cholangiography versus MR cholangiography. AJR Am J Roentgenol (2000) 1.23
Report of Joint Committee for Stroke Resources. IV. Brain edema in stroke. Stroke (1977) 1.22
Toxicology of cycasin. Cancer Res (1968) 1.22
Endothelial Ca2+ waves preferentially originate at specific loci in caveolin-rich cell edges. Proc Natl Acad Sci U S A (1998) 1.21
Endocannabinoids and neuroprotection. Sci STKE (2002) 1.20
A lack of intestinal pacemaker (c-kit) in aganglionic bowel of patients with Hirschsprung's disease. J Pediatr Surg (1995) 1.19
Variant strain of Propionibacterium acnes: a clue to the aetiology of Kawasaki disease. Lancet (1983) 1.19
Neurofibrillary spheroids induced by aluminum phosphate in dorsal root ganglia neurons in vitro. J Neuropathol Exp Neurol (1969) 1.18
Experimental cerebral ischemia in Mongolian gerbils. v. Ultrastructural changes in H3 sector of the hippocampus. Acta Neuropathol (1976) 1.17
18F-FDG PET imaging of muscle activity in runners. J Nucl Med (1999) 1.17
Ultrastructural observations on the transvascular route of protein removal in vasogenic brain edema. Acta Neuropathol (1985) 1.17
Fibrocellular tissue response after percutaneous transluminal coronary angioplasty. An immunocytochemical analysis of the cellular composition. Circulation (1991) 1.15
Degeneration of intrahepatic bile duct with lymphocyte infiltration into biliary epithelial cells in biliary atresia. J Pediatr Surg (1995) 1.14
Pyloromyotomy versus atropine sulfate for infantile hypertrophic pyloric stenosis. J Pediatr Surg (2000) 1.14
Double tracer methods in studies on blood-brain barrier dysfunction and brain edema. Acta Neurol Scand Suppl (1965) 1.13
Spontaneous rectus sheath hematomas: clinical and radiological features. Abdom Imaging (1996) 1.12
Action of cerebral ischemia on decreased levels of 3-methoxy-4-hydroxy-phenylethylgylcol sulfate, homovanillic acid and 5-hydroxy-indoleacetic acid produced by pargyline. Brain Res (1975) 1.12
Factors in the reproducibility of the gravimetric method for evaluation of edematous changes in the brain. Neurol Res (1981) 1.12
Presentation of myelin basic protein by murine cerebral vascular endothelial cells. J Immunol (1985) 1.11
Specific tension of elbow flexor and extensor muscles based on magnetic resonance imaging. Eur J Appl Physiol Occup Physiol (1994) 1.11
Experimental model for repetitive ischemic attacks in the gerbil: the cumulative effect of repeated ischemic insults. J Cereb Blood Flow Metab (1987) 1.11
Reversible osmotic opening of the blood-brain barrier. Science (1971) 1.11
Hypoxic preconditioning protects cultured neurons against hypoxic stress via TNF-alpha and ceramide. Am J Physiol Cell Physiol (2000) 1.10
Tyrosine-phosphorylated caveolin-1: immunolocalization and molecular characterization. Mol Biol Cell (1999) 1.10
The origin, migration and fine morphology of human primordial germ cells. Anat Rec (1977) 1.09
Regional patterns of blood-brain barrier breakdown during epileptiform seizures induced by various convulsive agents. J Neurol Sci (1983) 1.08
Internal tandem duplication of the FLT3 gene and clinical evaluation in childhood acute myeloid leukemia. The Children's Cancer and Leukemia Study Group, Japan. Leukemia (1999) 1.08
Temporary occlusion of the middle cerebral artery in the monkey: clinical and pathological observations. Stroke (1972) 1.08
Satisfaction with bispectral index monitoring of propofol-mediated sedation during endoscopic submucosal dissection: a prospective, randomized study. Endoscopy (2008) 1.06
The origin, migration and morphology of the primordial germ cells in the chick embryo. Anat Rec (1976) 1.06
Focal fatty masses of the pancreas. Acta Radiol (1995) 1.05
Mutations in the E-domain of RAR portion of the PML/RAR chimeric gene may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia. Blood (1998) 1.05
Prealbumin gene expression during mouse development studied by in situ hybridization. Cell Differ (1987) 1.05
Immune complex and mite antigen in Kawasaki disease. Lancet (1982) 1.04
Observation on cerebrospinal fluid pathways and behaviour of the blood-brain barrier in sharks. Acta Neuropathol (1965) 1.04
Experimental cerebral ischemia in Mongolian gerbils III. Behaviour of the blood-brain barrier. Acta Neuropathol (1976) 1.04
Structural basis for the altered drug sensitivities of non-small cell lung cancer-associated mutants of human epidermal growth factor receptor. Oncogene (2012) 1.04
Caveolin-1 isoforms are encoded by distinct mRNAs. Identification Of mouse caveolin-1 mRNA variants caused by alternative transcription initiation and splicing. FEBS Lett (2000) 1.02
Exclusively epidural arteriovenous fistula in the cervical spine with spinal cord symptoms: case report. Neurosurgery (2001) 1.02
Platelet-derived growth factor signals play critical roles in differentiation of longitudinal smooth muscle cells in mouse embryonic gut. Neurogastroenterol Motil (2008) 1.02
Mutational analysis of the N-ras gene in acute lymphoblastic leukemia: a study of 125 Japanese pediatric cases. Int J Hematol (1998) 1.02
Clinical characteristics of infant acute leukemia with or without 11q23 translocations. Leukemia (1988) 1.02
Mutations in the mitotic check point gene, MAD1L1, in human cancers. Oncogene (2001) 1.01
Brain oedema following brain ischaemia and the influence of therapy. Br J Anaesth (1985) 1.01
Behaviour of the blood-brain barrier toward biogenic amines in experimental cerebral ischemia. Adv Exp Med Biol (1980) 1.01
Observations on penetration of serum proteins into the central nervous system. Prog Brain Res (1965) 1.01
Diversity of leukaemic cell morphology in ATL correlates with prognostic factors, aberrant immunophenotype and defective HTLV-1 genotype. Br J Haematol (1999) 1.00